Scientists May Have Solved The Biggest Problem With Weight Loss Drugs

One of the most frustrating realities of modern weight loss medications, including the celebrated GLP-1 drugs like Ozempic and Wegovy, is what happens when people stop taking them — the weight comes back, often rapidly, because the fat cells that shrank during treatment are still there and ready to refill. A new injectable drug called CBL-514, developed by Taiwan-based Caliway Biopharmaceuticals and presented at the European Association for the Study of Diabetes annual meeting in October 2026, takes a fundamentally different approach by not shrinking fat cells but instead triggering them to destroy themselves entirely through a biological process called apoptosis. In phase 2 trials, participants on CBL-514 showed a 12 percent reduction in visceral fat at four weeks and roughly 10 percent at eight to twelve weeks, while those on placebo saw visceral fat increase by 6 percent and then 12 percent over the same period, a contrast that was both striking and statistically significant. Visceral fat, hidden deep within the abdomen and wrapped around the internal organs, is considered more dangerous to long-term health than subcutaneous fat and is strongly associated with heart disease, type 2 diabetes, and other metabolic conditions.

The hope extends to what happens after treatment ends, since animal studies showed that rats given both CBL-514 and the GLP-1 drug tirzepatide regained significantly less weight after tirzepatide was stopped than rats given tirzepatide alone, supporting the idea that by reducing the total number of fat cells, the body simply has less capacity to reaccumulate fat. "The hope is that CBL-514 will help people keep weight off," said Professor W. Timothy Garvey, who presented the data, noting that improvements in blood pressure, cholesterol, and blood sugar alongside the fat loss are what will ultimately matter most for long-term health. A phase 3 trial is already underway.

Source:https://medicalxpress.com/news/2026-10-weight-loss-fat-cells-cbl.html